Market
CPC Biotech debuts unified bioprocess fluid portfolio
CPC Biotech has launched as a unified brand combining CPC's biopharma connectors with PSG Biotech's pumps, flow meters, and sensors into an integrated bioprocess fluid management portfolio. The company will debut publicly at INTERPHEX 2026 in April at the Javits Center in New York City. The consolidation brings together critical fluid handling components and expertise for biopharmaceutical manufacturing.
The source
This brief is a MedIndexer summary of reporting by Medical Design & Outsourcing. To read the full story, head to the source.
Read the full story at Medical Design & Outsourcing